| 000 | 01388 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513070527.0 | ||
| 264 | 0 | _c19940127 | |
| 008 | 199401s 0 0 eng d | ||
| 022 | _a0090-1229 | ||
| 024 | 7 |
_a10.1006/clin.1994.1012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlasini, A M | |
| 245 | 0 | 0 |
_aT lymphocytes from patients with systemic lupus erythematosus show increased response to interleukin-2 after costimulation with OKT3 monoclonal antibody and phorbol esters. _h[electronic resource] |
| 260 |
_bClinical immunology and immunopathology _cJan 1994 |
||
| 300 |
_a66-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xmetabolism |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _ximmunology |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuromonab-CD3 _ximmunology |
| 650 | 0 | 4 |
_aReceptors, Interleukin-2 _xanalysis |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 700 | 1 | _aStekman, I L | |
| 700 | 1 | _aGonzalez, F | |
| 700 | 1 | _aTositti, M L | |
| 700 | 1 | _aRodriguez, M A | |
| 773 | 0 |
_tClinical immunology and immunopathology _gvol. 70 _gno. 1 _gp. 66-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/clin.1994.1012 _zAvailable from publisher's website |
| 999 |
_c8260954 _d8260954 |
||